Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C: Open Issues and Future Perspectives

Currently, two direct-acting antivirals (DAAs) show well-established efficacy against hepatitis C virus (HCV), namely, first-wave protease inhibitors telaprevir and boceprevir. Most clinical trials have examined DAAs in combination with standard of care (SOC) regimens. Future therapeutic drugs were...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Chae, Hee Bok, Park, Seon Mee, Youn, Sei Jin
Formato: Artigo
Idioma:Inglês
Publicado: Hindawi Publishing Corporation 2013
Assuntos:
Review Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687480/
https://ncbi.nlm.nih.gov/pubmed/23844410
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/704912
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares